{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:43:57Z","timestamp":1787021037717,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Salvage surgery following definitive radiotherapy or systemic treatment has become a feasible treatment option in selected patients with advanced initially unresectable non-small cell lung cancer. Recent clinical trials of neoadjuvant treatment have showed that surgery following immuno-chemotherapy is safely performed. Here, we present the first case of salvage surgery following immuno-chemotherapy with concurrent definitive radiotherapy for advanced lung large cell carcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 44-year male was admitted to our hospital for salvage surgery. Ten months prior to this administration, he had been diagnosed with unresectable large cell carcinoma with malignant pericardial effusion (clinical stage IVA\/T3N2M1A; no driver-gene alteration) originating from the right upper lobe (RUL). Due to rapid intrabronchial tumor growth causing severe dyspnea, emergency bronchial stenting in the right main bronchus using an expandable metallic stent had been performed. Thereafter, he had received immuno-chemotherapy with concurrent definitive radiotherapy. Despite dramatic radiographic response, he had suffered from persistent and refractory\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      lung infection associated with bronchial stent placement. As pericardial effusion had disappeared and no distant metastasis had developed, he was diagnosed with a potentially curable disease and was referred to our hospital. An extended sleeve resection was successfully performed, and pathological sections revealed that pathologic complete response was achieved with immuno-chemo-radiotherapy. The patient received no subsequent treatment, and is alive without tumor recurrence at 8\u00a0months after surgery.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Salvage surgery following immuno-chemotherapy with concurrent definitive radiotherapy for advanced non-small cell lung cancer may be feasible in selected patients, and may be considered as a treatment option to control local disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40792-022-01371-3","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T10:03:29Z","timestamp":1642759409000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Salvage surgery following immuno-chemo-radiotherapy for advanced non-small cell lung cancer"],"prefix":"10.1186","volume":"8","author":[{"given":"Ayako","family":"Nawashiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4692-6151","authenticated-orcid":false,"given":"Fumihiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Taira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Shinohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Shimajiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"1371_CR1","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.athoracsur.2020.10.035","volume":"11","author":"K Shimizu","year":"2021","unstructured":"Shimizu K, Ohtaki Y, Suzuki K, Date H, Yamashita M, Iizasa T, et al. Salvage surgery for non-small cell lung cancer after definitive radiotherapy. Ann Thorac Surg. 2021;11:862\u201373.","journal-title":"Ann Thorac Surg"},{"key":"1371_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.lungcan.2020.12.037","volume":"153","author":"Y Ohtaki","year":"2021","unstructured":"Ohtaki Y, Shimizu K, Suzuki H, Suzuki K, Tsuboi M, Mitsudomi T, et al. Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment. Lung Cancer. 2021;153:108\u201316.","journal-title":"Lung Cancer"},{"key":"1371_CR3","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S1470-2045(20)30453-8","volume":"21","author":"M Provencio","year":"2020","unstructured":"Provencio M, Nadal E, Insa A, Garc\u00eda-Campelo MR, Casal-Rubio J, D\u00f3mine M, et al. Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre single-arm, phase 2 trial. Lancet Oncol. 2020;21:1413\u201322.","journal-title":"Lancet Oncol"},{"key":"1371_CR4","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S1470-2045(20)30140-6","volume":"21","author":"CA Shu","year":"2020","unstructured":"Shu CA, Gainor JF, Awad MM, Chiuzan C, Grigg CM, Pabani A, et al. Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial. Lancet Oncol. 2020;21:786\u201395.","journal-title":"Lancet Oncol"},{"key":"1371_CR5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00276","author":"SI Rothschild","year":"2021","unstructured":"Rothschild SI, Zippelius A, Eboulet EI, Savic Prince S, Betticher D, Bettini A, et al. Durvalumab in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small-cell lung cancer\u2014a multicenter single-arm Phase II trial. J Clin Oncol. 2021. https:\/\/doi.org\/10.1200\/JCO.21.00276.","journal-title":"J Clin Oncol"},{"issue":"15 suppl","key":"1371_CR6","doi-asserted-by":"publisher","first-page":"8503","DOI":"10.1200\/JCO.2021.39.15_suppl.8503","volume":"39","author":"J Spicer","year":"2021","unstructured":"Spicer J, Wang C, Tanaka F, Saylors GB, Chen KN, Liberman M, et al. Surgical outcomes from the phase 3 CheckMate 816 trial: nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC). J Clin Oncol. 2021;39(15 suppl):8503.","journal-title":"J Clin Oncol"},{"key":"1371_CR7","doi-asserted-by":"publisher","first-page":"e844","DOI":"10.1200\/JOP.19.00770","volume":"16","author":"NH Hanna","year":"2020","unstructured":"Hanna NH, Temin S, Masters G. Therapy for stage IV non-small-cell lung cancer without driver alterations: ASCO and OH (CCO) Joint Guideline Update Summary. JCO Oncol Pract. 2020;16:e844\u20138.","journal-title":"JCO Oncol Pract."},{"key":"1371_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0140-6736(09)60737-6","volume":"374","author":"KS Albain","year":"2009","unstructured":"Albain KS, Swann RS, Rusch VW, Turrisi AT 3rd, Shepherd FA, Smith C, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet. 2009;374:379\u201388.","journal-title":"Lancet"},{"key":"1371_CR9","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1016\/j.athoracsur.2020.09.083","volume":"112","author":"K Minegishi","year":"2021","unstructured":"Minegishi K, Tsubochi H, Ohno K, Komori K, Ozeki M, Endo S. Salvage surgery post definitive chemoradiotherapy and durvalumab for lung cancer. Ann Thorac Surg. 2021;112:e53\u20135.","journal-title":"Ann Thorac Surg"},{"key":"1371_CR10","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.3390\/cancers13164033","volume":"13","author":"D Stefani","year":"2021","unstructured":"Stefani D, Pl\u00f6nes T, Viehof J, Darwiche K, Stuschke M, Schuler M, et al. Lung cancer surgery after neoadjuvant immunotherapy. Cancers (Basel). 2021;13:4033.","journal-title":"Cancers (Basel)."},{"key":"1371_CR11","unstructured":", University Hospital, Essen. phase-II trial of induction chemotherapy and chemoradiotherapy plus\/minus durvalumab and consolidation immunotherapy in patients with resectable stage III NSCLC. https:\/\/ClinicalTrials.gov\/show\/NCT04202809. Accessed on 9 January 2022."},{"key":"1371_CR12","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ejcts.2008.12.029","volume":"35","author":"RJ Cerfolio","year":"2009","unstructured":"Cerfolio RJ, Bryant AS, Jones VL, Cerfolio RM. Pulmonary resection after concurrent chemotherapy and high dose (60Gy) radiation for non-small cell lung cancer is safe and may provide increased survival. Eur J Cardiothorac Surg. 2009;35:718\u201323.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1371_CR13","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.jtcvs.2020.03.171","volume":"160","author":"JS Donington","year":"2020","unstructured":"Donington JS, Paulus R, Edelman MJ, Krasna MJ, Le QT, Suntharalingam M, et al. Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2020;160:1331\u201345.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1371_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.21037\/acs.2018.03.08","volume":"7","author":"E Folch","year":"2018","unstructured":"Folch E, Keyes C. Airway stents. Ann Cardiothorac Surg. 2018;7:273\u201383.","journal-title":"Ann Cardiothorac Surg."},{"key":"1371_CR15","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1378\/chest.127.6.2106","volume":"127","author":"W Lunn","year":"2005","unstructured":"Lunn W, Feller-Kopman D, Wahidi M, Ashiku S, Thurer R, Ernst A. Endoscopic removal of metallic airway stents. Chest. 2005;127:2106\u201311.","journal-title":"Chest"},{"key":"1371_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018627","volume":"99","author":"Y Bi","year":"2020","unstructured":"Bi Y, Wu G, Yu Z, Han X, Ren J. Fluoroscopic removal of self-expandable metallic airway stent in patients with airway stenosis. Medicine (Baltimore). 2020;99: e18627.","journal-title":"Medicine (Baltimore)"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-022-01371-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40792-022-01371-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-022-01371-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T10:05:34Z","timestamp":1642759534000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-022-01371-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1371"],"URL":"https:\/\/doi.org\/10.1186\/s40792-022-01371-3","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"assertion":[{"value":"20 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from the patient for the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}